Total Payments
$16,896
2024 Payments
$3,706
Companies
41
Transactions
889
Medicare Patients
6,019
Medicare Billing
$451,055
Payment Breakdown by Category
Food & Beverage$16,219 (96.0%)
Education$677.34 (4.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $16,219 | 876 | 96.0% |
| Education | $677.34 | 13 | 4.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,780 | 141 | $0 (2024) |
| Lilly USA, LLC | $1,680 | 78 | $0 (2024) |
| GENZYME CORPORATION | $1,403 | 73 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $1,351 | 49 | $0 (2024) |
| Janssen Biotech, Inc. | $1,262 | 58 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,192 | 75 | $0 (2024) |
| Galderma Laboratories, L.P. | $741.12 | 38 | $0 (2024) |
| Amgen Inc. | $721.03 | 40 | $0 (2024) |
| PFIZER INC. | $698.46 | 47 | $0 (2024) |
| Dermavant Sciences, Inc. | $535.83 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,706 | 215 | ABBVIE INC. ($537.10) |
| 2023 | $4,042 | 231 | Janssen Biotech, Inc. ($554.44) |
| 2022 | $2,894 | 147 | ABBVIE INC. ($761.31) |
| 2021 | $1,418 | 75 | SUN PHARMACEUTICAL INDUSTRIES INC. ($240.06) |
| 2020 | $1,051 | 62 | MAYNE PHARMA INC. ($243.12) |
| 2019 | $1,788 | 91 | AbbVie, Inc. ($247.78) |
| 2018 | $1,402 | 53 | Lilly USA, LLC ($321.86) |
| 2017 | $594.05 | 15 | AbbVie, Inc. ($203.65) |
All Payment Transactions
889 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: Immunology | ||||||
| 12/17/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.47 | General |
| Category: DERMATOLOGY | ||||||
| 12/13/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.27 | General |
| Category: Immunology | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.49 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.11 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: DERMATOLOGY | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.35 | General |
| Category: Immunology | ||||||
| 12/06/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: Dermatology | ||||||
| 12/05/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $11.89 | General |
| Category: DERMATOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $26.36 | General |
| Category: IMMUNOLOGY | ||||||
| 11/22/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Inflammation | ||||||
| 11/22/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.53 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $36.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/19/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: Immunology | ||||||
| 11/19/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.01 | General |
| Category: Dermatology | ||||||
| 11/19/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.72 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: DERMATOLOGY | ||||||
| 11/16/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Immunology | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $27.05 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.83 | General |
| Category: DERMATOLOGY | ||||||
| 11/06/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Arcutis Biotherapeutics, Inc. | Zoryve (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: Dermatology | ||||||
| 11/05/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,903 | 3,475 | $446,445 | $140,946 |
| 2022 | 15 | 1,635 | 2,961 | $393,250 | $121,102 |
| 2021 | 16 | 1,321 | 2,398 | $324,079 | $107,663 |
| 2020 | 13 | 1,160 | 2,005 | $259,538 | $81,344 |
Total Patients
6,019
Total Services
10,839
Medicare Billing
$451,055
Procedure Codes
60
All Medicare Procedures & Services
60 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 394 | 565 | $105,090 | $33,848 | 32.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 259 | 337 | $79,532 | $26,701 | 33.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 188 | $47,564 | $16,490 | 34.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 287 | 391 | $53,176 | $13,550 | 25.5% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 195 | 216 | $46,872 | $13,330 | 28.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 150 | 150 | $34,200 | $11,116 | 32.5% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 225 | 1,275 | $17,850 | $6,349 | 35.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 52 | 52 | $17,680 | $4,760 | 26.9% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2023 | 30 | 33 | $10,131 | $3,792 | 37.4% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 26 | 30 | $10,290 | $3,558 | 34.6% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 42 | 55 | $6,050 | $2,116 | 35.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 49 | 50 | $5,750 | $2,025 | 35.2% |
| 17111 | Destruction of skin growth, 15 or more growths | Office | 2023 | 12 | 15 | $4,140 | $1,433 | 34.6% |
| 17261 | Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | Office | 2023 | 15 | 16 | $4,912 | $1,362 | 27.7% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2023 | 11 | 14 | $1,624 | $445.64 | 27.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 17 | 88 | $1,584 | $70.83 | 4.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 313 | 470 | $87,420 | $27,694 | 31.7% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 218 | 283 | $66,788 | $22,145 | 33.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 186 | 213 | $46,221 | $12,413 | 26.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 104 | 143 | $36,179 | $12,216 | 33.8% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 251 | 353 | $48,008 | $11,759 | 24.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 155 | 155 | $35,340 | $10,920 | 30.9% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 185 | 1,095 | $15,330 | $5,580 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 51 | 51 | $17,340 | $4,742 | 27.3% |
| 17262 | Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm | Office | 2022 | 32 | 35 | $10,745 | $3,917 | 36.5% |
About Dr. Christopher Stroud, MD
Dr. Christopher Stroud, MD is a Dermatology healthcare provider based in Mckinney, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2013. The National Provider Identifier (NPI) number assigned to this provider is 1831431147.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Stroud, MD has received a total of $16,896 in payments from pharmaceutical and medical device companies, with $3,706 received in 2024. These payments were reported across 889 transactions from 41 companies. The most common payment nature is "Food and Beverage" ($16,219).
As a Medicare-enrolled provider, Stroud has provided services to 6,019 Medicare beneficiaries, totaling 10,839 services with total Medicare billing of $451,055. Data is available for 4 years (2020–2023), covering 60 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatology
- Location Mckinney, TX
- Active Since 03/25/2013
- Last Updated 07/30/2025
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1831431147
Products in Payments
- DUPIXENT (Biological) $2,524
- TALTZ (Drug) $1,654
- SKYRIZI (Biological) $1,306
- TREMFYA (Drug) $1,136
- Otezla (Drug) $835.89
- RINVOQ (Biological) $789.71
- ILUMYA (Biological) $649.50
- EUCRISA (Drug) $637.92
- Humira (Biological) $596.62
- VTAMA (Drug) $535.83
- OPZELURA (Drug) $483.49
- ADBRY (Biological) $342.48
- DUPIXENT (Drug) $325.77
- ORACEA (Drug) $314.77
- COSENTYX (Biological) $312.68
- DORYX (Drug) $265.55
- Zoryve (Drug) $227.38
- Winlevi (Drug) $223.80
- Seysara (Drug) $200.57
- DUOBRII (Drug) $174.55
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Mckinney
Robert Marinaro, Md, MD
Dermatology — Payments: $59,798
Dermatology $59,798
James Ralston, M.d, M.D
Dermatology — Payments: $20,680
Dermatology $20,680
Julie Darby, Pa- C, PA- C
Dermatology — Payments: $6,373
Dermatology $6,373
Jonathan Richey, Do, Mha, DO, MHA
Dermatology — Payments: $4,626
Dermatology $4,626
Whitney Gao, Md, MD
Dermatology — Payments: $4,031
Dermatology $4,031
Matthew Barrows, Md, MD
Dermatology — Payments: $3,726
Dermatology $3,726